Michael D. Rainey
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Cell Biology top 5%
- Microtubule and mitosis dynamics
Papers in
-
- DNA Repair Mechanisms 18
- Mitochondrial Function and Pathology 3
- Cancer therapeutics and mechanisms 3
- Ubiquitin and proteasome pathways 2
- Oncology 12
- Cancer-related Molecular Pathways 9
- PARP inhibition in cancer therapy 3
- Co-authors
- David A. Gillespie (5 shared papers)George Zachos (5 shared papers)Corrado Santocanale (14 shared papers)Michael B. Kastan (1 shared paper)Maura E. Charlton (1 shared paper)Robert V. Stanton (1 shared paper)David C. A. Gaboriau (3 shared papers)Martin Willer (1 shared paper)
- Journals
- Cancer Research (2 papers)Cell Cycle (2 papers)Oncogene (2 papers)Journal of Clinical Oncology (1 paper)iScience (1 paper)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Michael D. Rainey
26 papers receiving 954 citations
Peers
Comparison fields: 5 of 74
- Oncology 381
- Cell Biology 247
- Molecular Biology 781
- Cancer Research 135
- Pathology and Forensic Medicine 53
Countries citing papers authored by Michael D. Rainey
This map shows the geographic impact of Michael D. Rainey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Rainey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Rainey more than expected).
Fields of papers citing papers by Michael D. Rainey
This network shows the impact of papers produced by Michael D. Rainey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Rainey. The network helps show where Michael D. Rainey may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael D. Rainey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 200 | |
| 2 | 2008 | 194 | |
| 3 | 2005 | 72 | |
| 4 | 1999 | 60 | |
| 5 | 2011 | 47 | |
| 6 | 2016 | 44 | |
| 7 | 1985 | 36 | |
| 8 | 2015 | 34 | |
| 9 | 2020 | 34 | |
| 10 | 2007 | 33 | |
| 11 | 2013 | 29 | |
| 12 | 2016 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2020 | 23 | |
| 15 | 2015 | 23 | |
| 16 | 2013 | 17 | |
| 17 | 2011 | 13 | |
| 18 | 2013 | 13 | |
| 19 | 2014 | 11 | |
| 20 | Molecular modeling and in-silico characterization of Glycine max inositol (1, 3, 4) tris 5/6 kinase-1(Gmitpk1) - a potential candidate gene for developing low phytate transgenics. | 2015 | 6 |
About Michael D. Rainey
Michael D. Rainey is a scholar working on Molecular Biology, Oncology, Cell Biology, Plant Science and Cancer Research, having authored 27 papers that have together received 966 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (18 papers), Microtubule and mitosis dynamics (9 papers), Cancer-related Molecular Pathways (9 papers), Carcinogens and Genotoxicity Assessment (3 papers), PARP inhibition in cancer therapy (3 papers), Mitochondrial Function and Pathology (3 papers), Cancer therapeutics and mechanisms (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (381 citations), Cell Biology (247 citations), Molecular Biology (781 citations), Cancer Research (135 citations) and Pathology and Forensic Medicine (53 citations). Michael D. Rainey has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include David A. Gillespie, George Zachos, Corrado Santocanale, Michael B. Kastan, Maura E. Charlton, Robert V. Stanton, David C. A. Gaboriau, Martin Willer, Brendan Harhen and Timothy J. Pullen. Their work appears in journals such as Cancer Research, Cell Cycle, Oncogene, Journal of Clinical Oncology and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.